Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
09/04/2014 | WO2014133401A1 High dose extended-release potassium citrate wax matrix tablet |
09/04/2014 | WO2014133351A1 Composition for gene delivery comprising chitosan and liquid crystal formation material |
09/04/2014 | WO2014133204A1 Heat releasing composition comprising shape anisotropic nanomaterial |
09/04/2014 | WO2014133196A1 Suspension for oral administration comprising amorphous tolvaptan |
09/04/2014 | WO2014132262A1 Peptide-based hydrogel particles and uses thereof |
09/04/2014 | WO2014132163A1 Enhanced stability of novel liquid compositions |
09/04/2014 | WO2014132134A1 A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same |
09/04/2014 | WO2014131191A1 A composition containing honokiol and/or magnolol and uses thereof |
09/04/2014 | WO2014131122A1 Formulations of growth hormone releasing factor (grf) molecules with improved stability |
09/04/2014 | WO2014080285A3 Pharmaceutical compositions having improved storage stability |
09/04/2014 | US20140249235 Pharmaceutical Compositions With Enhanced Performance and Improved Processability |
09/04/2014 | US20140249232 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
09/04/2014 | US20140249231 Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same |
09/04/2014 | US20140249230 Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same |
09/04/2014 | US20140249229 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
09/04/2014 | US20140249228 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
09/04/2014 | US20140249213 Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents |
09/04/2014 | US20140249202 Targeted nanoparticles |
09/04/2014 | US20140249184 Polymer-based surgically implatable haloperidol delivery systems and methods for their production and use |
09/04/2014 | US20140249171 Oral formulations and lipophilic salts of methylnaltrexone |
09/04/2014 | US20140249124 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
09/04/2014 | US20140249123 Extended release biodegradable ocular implants |
09/04/2014 | US20140249098 Pharmaceutical Composition Comprising Dapagliflozin and Cyclodextrin |
09/04/2014 | US20140249093 Carrier-Linked Prodrugs Having Reversible Carboxylic Ester Linkages |
09/04/2014 | US20140249092 Cyclosporin analog formulations |
09/04/2014 | US20140249083 Formulations of growth hormone releasing factor (grf) molecules with improved stability |
09/04/2014 | US20140249079 Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anonic polymer |
09/04/2014 | US20140249077 Gel compositions |
09/04/2014 | US20140249076 Amylin-calcitonin chimeric peptides conjugated to duration enhancing moieties |
09/04/2014 | US20140249031 Micelle-coated crystalline particles |
09/04/2014 | US20140248410 Carotenoid-containing composition and method for producing same |
09/04/2014 | US20140248364 Divalent-metal coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation |
09/04/2014 | US20140248358 Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same |
09/04/2014 | US20140248353 Dosage form for insertion into the mouth |
09/04/2014 | US20140248351 Pharmaceutical composition comprising fesoterodine |
09/04/2014 | US20140248339 Multi-component nanochains |
09/04/2014 | US20140248334 Peptides that target dorsal root ganglion neurons |
09/04/2014 | US20140248330 Device for transdermal administration of drugs including acrylic polymers |
09/04/2014 | US20140248313 Combination adjuvant formulation |
09/04/2014 | US20140248312 Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
09/04/2014 | US20140248298 Bioresorable polymer matrices and methods of making and using the same |
09/04/2014 | US20140248296 Sustained drug delivery system |
09/04/2014 | US20140248282 Novel anti-ddr1 antibody having anti-tumor activity |
09/04/2014 | US20140248274 Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies |
09/04/2014 | US20140248270 Method for topical treatment of tar-responsive dermatological disorders |
09/04/2014 | US20140248267 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same |
09/04/2014 | US20140248249 Method for stabilization and delivery of therapeutic molecules |
09/04/2014 | US20140248234 Use of g-csf dimer in preparation of medicament for treatment of neurodegenerative diseases |
09/04/2014 | US20140248223 Film compositions for delivery of actives |
09/04/2014 | US20140248219 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
09/04/2014 | US20140248216 Drug delivery by carbon nanotube arrays |
09/04/2014 | US20140248214 High-concentration aqueous dispersions of graphene using nonionic, biocompatible copolymers |
09/04/2014 | US20140248211 Method of treating cancer |
09/04/2014 | US20140248210 Multimodal silica-based nanoparticles |
09/04/2014 | US20140248209 Anti-tumoral compound and relative production process |
09/04/2014 | DE10297513C5 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes |
09/03/2014 | EP2772500A1 Site-directed modification of FVIII |
09/03/2014 | EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof |
09/03/2014 | EP2772497A1 Controlled synthesis of polyglutamates with low polydispersity and versatile architectures |
09/03/2014 | EP2772270A1 Emulsified hydrogel composition and a production method therefor |
09/03/2014 | EP2772257A1 Formulations of quinolinones |
09/03/2014 | EP2772252A1 Oxybutynin-containing transdermal absorption preparation |
09/03/2014 | EP2772251A1 Protamine/RNA nanoparticles for immunostimulation |
09/03/2014 | EP2772249A1 Method and composition for treating ocular hypertension and glaucoma |
09/03/2014 | EP2772247A1 Surface-modified ultraviolet blocking powder and ultraviolet blocking composition including same |
09/03/2014 | EP2771034A1 Treatment of patients suffering from cancer |
09/03/2014 | EP2771033A1 Protein formulations containing amino acids |
09/03/2014 | EP2771027A1 Hemostatic compositions |
09/03/2014 | EP2771023A1 Oral formulations mimetic of roux-en-y gastric bypass actions on the ileal brake; compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and t2d |
09/03/2014 | EP2770980A1 Limit size lipid nanoparticles and related methods |
09/02/2014 | US8822675 Low-substituted hydroxypropylcellulose and solid preparation comprising the same |
09/02/2014 | US8822650 Method for the mass production of immunoglobulin constant region |
09/02/2014 | US8822636 Peptides for activation and inhibition of δPKC |
09/02/2014 | US8822551 Implantation material comprising biocompatible polymer |
09/02/2014 | US8822549 Buffered oxygen therapeutic |
09/02/2014 | US8822546 Flowable pharmaceutical depot |
09/02/2014 | US8822543 Method of using punicic acid to enhance immune response and prevent metabolic disorders |
09/02/2014 | US8822493 SNS-595 and methods of using the same |
09/02/2014 | US8822477 Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis |
09/02/2014 | US8822410 Tympanic membrane permeating ear drops and uses thereof |
09/02/2014 | US8822406 Tumor activated prodrugs |
09/02/2014 | US8822213 Bispecific intracellular delivery vehicles |
09/02/2014 | US8821936 Solid pharmaceutical formulation |
09/02/2014 | US8821935 Microcapsules with modified release of active principles with low solubility for oral delivery |
09/02/2014 | US8821934 Pullulan-containing powder, process for producing the same and use thereof |
09/02/2014 | US8821933 Polymers and hydrogels |
09/02/2014 | US8821929 Tamper resistant dosage forms |
09/02/2014 | US8821918 Cross-linked gelatin composition comprising a wetting agent |
09/02/2014 | US8821915 Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
09/02/2014 | US8821902 Powdery emulsifying composition of alkyl polyglycosides, use thereof for preparing cosmetic emulsions, and method for preparing same |
09/02/2014 | US8821899 Method and process for the production of multi-coated recognitive and releasing systems |
09/02/2014 | US8821859 Methods and articles for the delivery of therapeutic agents |
09/02/2014 | US8821850 Protein-polymer-drug conjugates |
09/02/2014 | US8821836 SPARC binding peptides and uses thereof |
09/02/2014 | US8821835 Flexible and/or elastic brachytherapy seed or strand |
09/02/2014 | CA2652967C Hydrogels of polysaccharide mixtures for tissue engineering and as carriers of active compounds |
09/02/2014 | CA2642952C Pharmaceutical composition comprising oseltamivir phosphate |
08/28/2014 | WO2014130998A1 Surface functionalized porous silicon |
08/28/2014 | WO2014130938A1 Particle formulations for delivery of tlr agonists and antigens |
08/28/2014 | WO2014130879A2 Novel antibody conjugates and uses thereof |